Do COL1A1 or COL1A2 Variants Confirm Arthrochalasia EDS?
Yes, specific pathogenic variants in COL1A1 or COL1A2 genes can confirm arthrochalasia-type Ehlers-Danlos syndrome (aEDS), but only when they affect exon 6 or its splice sites, leading to loss of the N-terminal propeptide cleavage site of type I procollagen. The clinical phenotype must also align with aEDS features to establish the diagnosis.
Genetic Confirmation Criteria
The molecular diagnosis of aEDS is highly specific:
- Classic aEDS (autosomal dominant): Heterozygous variants causing complete or partial skipping of exon 6 in COL1A1 or COL1A2 1, 2
- Rare recessive form: Homozygous missense variant c.2050G>A (p.Glu684Lys) in COL1A1, predominantly reported in Saudi Arabian families as a founder mutation 3, 4
Critical distinction: Not all COL1A1/COL1A2 variants cause aEDS. These genes are also responsible for:
- Osteogenesis imperfecta (OI) - most common
- Classical EDS (cEDS) - arginine-to-cysteine substitutions 5, 6
- Vascular EDS features - certain glycine substitutions 6
- COL1-related overlap disorders 7, 6
Clinical Features Required for Diagnosis
The genetic finding must correlate with the characteristic aEDS phenotype 1, 2:
Major features (must be present):
- Congenital bilateral hip dislocation
- Severe generalized joint hypermobility
- Recurrent joint subluxations/dislocations
- Skin hyperextensibility
- Muscle hypotonia (especially in infancy)
Additional features:
- Mild dysmorphic facial features
- Kyphoscoliosis
- Fractures (more common with COL1A1 exon 6 variants) 2
- Potential wheelchair dependence in adulthood (4/12 patients in one series) 2
Genotype-Phenotype Correlations
Important clinical distinctions 2, 6:
- COL1A1 exon 6 variants: More severe musculoskeletal involvement, higher fracture risk, more likely to require orthopedic interventions
- COL1A2 exon 6 variants: Similar joint hypermobility but potentially less severe bone fragility
- Homozygous p.Glu684Lys: Intermediate severity between severe neonatal OI and classical EDS, with prominent hypotonia and arthrochalasia features 3
Diagnostic Algorithm
When COL1A1/COL1A2 variants are identified:
Determine variant location and type:
Assess clinical phenotype dominance:
Evaluate for vascular complications:
Critical Pitfalls to Avoid
Do not assume all COL1A1/COL1A2 variants cause aEDS 8. The 2001 European Heart Journal guideline notes that mutations in these genes are "not specific" and are found across multiple EDS types and OI. The specific molecular mechanism (exon 6 skipping) is what defines aEDS.
Beware of misclassification: One case initially diagnosed as hypermobile EDS (hEDS) was later found to have a COL1A2 variant 6. This highlights that some clinically diagnosed hEDS cases may have molecular diagnoses in COL1A2.
Consider recessive inheritance: In consanguineous families or when both parents are carriers, look for the homozygous p.Glu684Lys variant, which presents with severe congenital hypotonia that may initially mimic neuromuscular disorders 3.
Management Implications
Once aEDS is genetically confirmed 2:
- Orthopedic surveillance: Hip surgery required in 5/12 patients, spinal surgery in 3/12
- Fracture management: Bisphosphonates may be needed (1/12 patients required treatment)
- Cardiovascular monitoring: Echocardiography despite lower vascular risk than vascular EDS
- Pregnancy counseling: Preterm labor risk but generally manageable (one patient had two successful pregnancies)
- Functional prognosis: Majority of adults can maintain careers, but mobility aids may be necessary
The variant alone does not confirm aEDS—correlation with the clinical phenotype, particularly congenital hip dislocation and severe joint hypermobility, is essential for accurate diagnosis 1, 2.